GGrantIndex
← Leaderboards

David W. Speicher

Wistar Institute

Google Scholar ↗PubMed ↗ORCID ↗
$30,175,378
Attributed
$32,662,335
Total exposure
19
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY2005–24
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$32,662,335 · 19

By mechanism

R01$16,422,360 · 6
P30$5,295,279 · 3
P01$4,823,905 · 4
R33$3,270,099 · 2
T32$1,584,788 · 1
S10$1,100,000 · 2

Top collaborators

Most similar at Wistar Institute

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics”

Research focus

ProteomicsProteinsSamplingMass Spectrum AnalysisMass SpectrometryBaseProteomeMolecularCell LinePerformanceCellsTumor TissueBloodEarly DiagnosisMass SpectrometerFutureBiomarkerComplexHigh Performance Liquid ChromatographyRecombinant ProteinsCohortPlasmaBiologicalProtein Structure Function

Grant awards (84)

Proteomics and Metabolomics Shared Resource$2,833,735
P30 · FY2024 · CA · contact PI
Proteomics and Metabolomics Shared Resource$749,999
P30 · FY2024 · CA · contact PI
Proteomics and Metabolomics Shared Resource$206,619
P30 · FY2023 · CA · contact PI
Proteomics and Metabolomics Shared Resource$206,619
P30 · FY2022 · CA · contact PI
Proteomics and Metabolomics Shared Resource$206,619
P30 · FY2021 · CA · contact PI
Proteomics and Metabolomics Shared Resource$191,862
P30 · FY2020 · CA · contact PI
Core B - Mass Spectrometry$187,399
P01 · FY2020 · CA · contact PI
Proteomics and Metabolomics Shared Resource$206,619
P30 · FY2019 · CA · contact PI
Core B - Mass Spectrometry$166,154
P01 · FY2019 · CA · contact PI
Predoctoral Training at the Chemistry-Biology Interface$102,850
T32 · FY2019 · GM
Identification of Ovarian Cancer Plasma Biomarkers$452,569
R01 · FY2018 · CA · contact PI
Predoctoral Training at the Chemistry-Biology Interface$282,086
T32 · FY2018 · GM
Core B - Mass Spectrometry$171,818
P01 · FY2018 · CA · contact PI
Purchase of a Q Exactive HF mass spectrometer system for metabolomics$600,000
S10 · FY2017 · OD · contact PI
Identification of Ovarian Cancer Plasma Biomarkers$452,569
R01 · FY2017 · CA · contact PI
Predoctoral Training at the Chemistry-Biology Interface$279,627
T32 · FY2017 · GM
Core B - Mass Spectrometry$173,966
P01 · FY2017 · CA · contact PI
Identification of Ovarian Cancer Plasma Biomarkers$452,569
R01 · FY2016 · CA · contact PI
Predoctoral Training at the Chemistry-Biology Interface$276,636
T32 · FY2016 · GM
Core B - Mass Spectrometry$212,054
P01 · FY2016 · CA · contact PI
Identification of Ovarian Cancer Plasma Biomarkers$440,659
R01 · FY2015 · CA · contact PI
Predoctoral Training at the Chemistry-Biology Interface$273,682
T32 · FY2015 · GM
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users$701,027
R01 · FY2014 · DA
Identification of Ovarian Cancer Plasma Biomarkers$440,659
R01 · FY2014 · CA · contact PI
Predoctoral Training at the Chemical-Biology Interface$146,634
T32 · FY2014 · GM · contact PI
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users$678,291
R01 · FY2013 · DA
Membrane Proteins of Normal and Abnormal Red Cells$433,442
R01 · FY2013 · HL · contact PI
Predoctoral Training at the Chemical-Biology Interface$223,273
T32 · FY2013 · GM · contact PI
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users$678,940
R01 · FY2012 · DA
Membrane Proteins of Normal and Abnormal Red Cells$466,486
R01 · FY2012 · HL · contact PI
Identification of ovarian cancer plasma biomarkers$428,620
R01 · FY2012 · CA · contact PI
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users$665,484
R01 · FY2011 · DA
Membrane Proteins of Normal and Abnormal Red Cells$466,485
R01 · FY2011 · HL · contact PI
Identification of ovarian cancer plasma biomarkers$413,376
R01 · FY2011 · CA · contact PI
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users$665,385
R01 · FY2010 · DA
Membrane Proteins of Normal and Abnormal Red Cells$471,198
R01 · FY2010 · HL · contact PI
Identification of ovarian cancer plasma biomarkers$426,197
R01 · FY2010 · CA · contact PI
Discovery and validation of novel serological biomarkers of colon cancer$386,939
R01 · FY2010 · CA · contact PI
Identification of ovarian cancer plasma biomarkers$567,699
R01 · FY2009 · CA · contact PI
Membrane Proteins of Normal and Abnormal Red Cells$457,472
R01 · FY2009 · HL · contact PI
Discovery and validation of novel serological biomarkers of colon cancer$415,152
R01 · FY2009 · CA · contact PI
Protein Modification with Oxidative Stress in ALI$356,671
P01 · FY2009 · HL · contact PI
Proteomics Facility$92,462
P30 · FY2009 · CA · contact PI
Protein Modification with Oxidative Stress in ALI$612,635
P01 · FY2008 · HL · contact PI
Discovery and validation of novel serological biomarkers of colon cancer$350,366
R01 · FY2008 · CA · contact PI
Purchase of an ion trap mass spectrometer$500,000
S10 · FY2007 · RR · contact PI
Protein Modification with Oxidative Stress in ALI$431,310
P01 · FY2007 · HL · contact PI
Discovery and validation of novel serological biomarkers of colon cancer$320,521
R01 · FY2007 · CA · contact PI
Membrane Proteins of Normal & Abnormal Red Cells$425,931
R01 · FY2006 · HL · contact PI
Protein Modification with Oxidative Stress in ALI$405,517
P01 · FY2006 · HL · contact PI
Discovery and validation of novel serological biomarkers of colon cancer$405,414
R01 · FY2006 · CA · contact PI
Protein Modification with Oxidative Stress in ALI$426,398
P01 · FY2005 · HL
Membrane Proteins of Normal &Abnormal Red Cells$423,475
R01 · FY2005 · HL
Technologies for Identifying Proteins Secreted by Tumors$325,610
R01 · FY2005 · CA
Novel Comprehensive Proteome Analyses of Metastasis$602,469
R33 · FY2004 · CA
Development of Methods for Cancer Biomarker Detection$416,082
R33 · FY2004 · CA
Membrane Proteins of Normal &Abnormal Red Cells$411,141
R01 · FY2004 · HL
Technologies for Identifying Proteins Secreted by Tumors$313,085
R01 · FY2004 · CA
Novel Comprehensive Proteome Analyses of Metastasis$641,921
R33 · FY2003 · CA
Development of Methods for Cancer Biomarker Detection$480,464
R33 · FY2003 · CA
Membrane Proteins of Normal &Abnormal Red Cells$399,165
R01 · FY2003 · HL
Technologies for Identifying Proteins Secreted by Tumors$375,222
R01 · FY2003 · CA
Novel Comprehensive Proteome Analyses of Metastasis$697,815
R33 · FY2002 · CA
Membrane Proteins of Normal &Abnormal Red Cells$454,038
R01 · FY2002 · HL
Development of Methods for Cancer Biomarker Detection$431,348
R33 · FY2002 · CA
Technologies for Identifying Proteins Secreted by Tumors$354,491
R01 · FY2002 · CA
CORE--BIOCHEMISTRY CORE$312,755
P01 · FY2002 · CA
CORE--BIOCHEMISTRY CORE$312,755
P01 · FY2002 · CA
STRUCTURE/FUNCTION OF THE CO17-1A/GA733 ANTIGEN$228,401
P01 · FY2002 · CA
CORE--PROTEIN MICROCHEMISTRY/MASS SPECTROMETRY FACILITY$0
P30 · FY2002 · CA
CORE--PROTEIN MICROCHEMISTRY/MASS SPECTROMETRY FACILITY$0
P30 · FY2002 · CA
MEMBRANE PROTEINS OF NORMAL/ABNORMAL RED CELLS$342,342
R01 · FY2001 · HL
CORE--BIOCHEMISTRY CORE$312,755
P01 · FY2001 · CA
STRUCTURE/FUNCTION OF THE CO17-1A/GA733 ANTIGEN$228,401
P01 · FY2001 · CA
CORE--PROTEIN MICROCHEMISTRY/MASS SPECTROMETRY FACILITY$220,099
P30 · FY2001 · CA
Novel Comprehensive Proteome Analyses of Metastasis$165,904
R21 · FY2001 · CA
CORE--PROTEIN MICROCHEMISTRY/MASS SPECTROMETRY FACILITY$0
P30 · FY2001 · CA
MEMBRANE PROTEINS OF NORMAL/ABNORMAL RED CELLS$332,371
R01 · FY2000 · HL
STRUCTURE FUNCTION OF MELCAM, A CELL ADHESION PROTEIN$318,690
R01 · FY2000 · CA
TECHNOLOGIES FOR IDENTIFYING PROTEINS SECRETED BY TUMORS$309,280
R01 · FY2000 · CA
CORE--PROTEIN MICROCHEMISTRY/MASS SPECTROMETRY FACILITY$220,099
P30 · FY2000 · CA
CORE--PROTEIN MICROCHEMISTRY/MASS SPECTROMETRY FACILITY$160,547
P30 · FY2000 · CA
STRUCTURE/FUNCTION OF THE CO17-1A/GA733 ANTIGEN$154,053
P01 · FY2000 · CA
CORE--BIOCHEMISTRY CORE$130,863
P01 · FY2000 · CA